Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
1 March 2017
Question for written answer
to the Commission
Rule 130
Damiano Zoffoli (S&D)

 Subject:  Measures to recover useful medicines not yet past their sell-by date

Throughout Europe, tonnes of still-valuable drugs are regularly being thrown away, causing not only environmental damage but also economic damage to national health systems.

In addition, millions of poor people in Europe cannot afford to buy the drugs necessary for their health.

Given the above, and in view also of Parliament’s own-initiative report on ‘EU options for improving access to medicines’ (2016/2057(INI)) and some successful experiences at Member State level, such as the campaign to recover useful medicines conducted by the Italian ‘Pharmaceutical Bank’ non-profit organisation, can the Commission say whether it is aware of the great waste of medicines taking place every day in Europe? Should it not make representations to the EU and the Member States to promote measures to counter such waste, also with a view to recovering effective medicines that have not yet expired?

Original language of question: IT 
Last updated: 22 March 2017Legal notice